FASEB Names New President and Officers

July 05, 2017

On July 1, Thomas O. Baldwin, PhD, began his year-long term as President of the Federation of American Societies for Experimental Biology (FASEB). Dr. Baldwin is Professor Emeritus of Biochemistry at University of California, Riverside, where he also served as Dean of the College of Natural and Agricultural Sciences. He has served in numerous roles within FASEB, including on the Science Research Conference Committee and the Finance Committee. He serves on the FASEB Public Affairs Committee and the Science Policy Committee, and represented the American Society for Biochemistry and Molecular Biology on the FASEB board.

“FASEB has always provided vital advocacy and other services to the biological sciences, but now is an especially critical time,” said Dr. Baldwin.  “As I begin my presidency, science is under attack in ways that we have not experienced in my lifetime. It is more important than ever that all scientists and scientific societies, whether members of FASEB or not, work together to assure that future generations benefit from the vitality of American science that has contributed so much to the quality of life that we now take for granted.”

Dr. Baldwin’s research career focused primarily on the structure and function of the enzyme bacterial luciferase, a flavin monooxygenase that confers the ability to emit light – bioluminescence – on certain primarily marine bacteria. His lab determined the enzyme’s structure, how it is assembled, and how it interacts with other proteins. His group also developed clinical applications for the enzyme, leveraging bioluminescence to monitor biological processes in cells.

Other new FASEB officers include Vice President for Science Policy Hannah V. Carey, PhD, Professor of Comparative Biosciences at the University of Wisconsin School of Veterinary Medicine. Dr. Carey’s research interests are in the areas of gastrointestinal physiology and hibernation biology.

James M. Musser, MD, PhD, became President-Elect July 1. He is Fondren Distinguished Presidential Endowed Chair in the Department of Pathology and Genomic Medicine, and Director of the Center for Molecular and Translational Human Infectious Diseases Research at Houston Methodist Hospital and Research Institute. Louis B. Justement, PhD – Professor of Microbiology at the University of Alabama at Birmingham – became Vice President-Elect for Science Policy.

Categories: FASEB General Announcements;